Patient‐centred and professional‐directed implementation strategies for diabetes guidelines: a cluster‐randomized trial‐based cost‐effectiveness analysis
暂无分享,去创建一个
E. Adang | R. Grol | R. Dijkstra | J. Braspenning | R. F. Dijkstra | L. W. Niessen | J. C. C. Braspenning | E. Adang | R. T. P. M. Grol | Prof Louis W Niessen | L Niessen
[1] G. Rutten,et al. NHG-standaard Diabetes Mellitus type 2 (eerste herziening) , 1999 .
[2] J M Grimshaw,et al. Effectiveness and efficiency of guideline dissemination and implementation strategies , 2004, International Journal of Technology Assessment in Health Care.
[3] L. Niessen,et al. Cost-effectiveness of glycemic control and ophthalmological care in diabetic retinopathy. , 2003, Health policy.
[4] T. Sano,et al. [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.
[5] E. Standl,et al. Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the Greater Munich Area , 1993, Diabetologia.
[6] Paul Fenn,et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) , 2000, BMJ : British Medical Journal.
[7] P. Bingley,et al. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes , 2002, Diabetologia.
[8] H. King,et al. Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.
[9] D. Klonoff,et al. An economic analysis of interventions for diabetes. , 2000, Diabetes care.
[10] R. Dijkstra,et al. Patients and nurses determine variation in adherence to guidelines at Dutch hospitals more than internists or settings , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[11] P. Zimmet,et al. The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010 , 1997, Diabetic medicine : a journal of the British Diabetic Association.
[12] R. Glasgow,et al. In diabetes care, moving from compliance to adherence is not enough. Something entirely different is needed. , 1999, Diabetes care.
[13] L. Niessen. Roads To Health: Multi-State Modelling Of Population Health And Resource Use , 2003 .
[14] Harlan M Krumholz,et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. , 2002, Journal of the American College of Cardiology.
[15] J. Rakela,et al. Gedetailleerde raming van de maatschappelijke kosten van diabetes mellitus , 2000 .
[16] L. Niessen,et al. Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis. , 2004, Diabetes care.
[17] R. Hutubessy,et al. Stochastic league tables: an application to diabetes interventions in the Netherlands. , 2005, Health economics.
[18] J. Bommer,et al. Prevalence and socio-economic aspects of chronic kidney disease. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[19] Jan B Oostenbrink,et al. Standardisation of costs: the Dutch Manual for Costing in economic evaluations. , 2002, PharmacoEconomics.
[20] H. Bilo,et al. Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines. , 2000, Health policy.
[21] R. Ratner. Type 2 diabetes mellitus: the grand overview , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[22] M. Koopmanschap,et al. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. , 2002, Diabetes care.
[23] P. M. Brown,et al. Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[24] E. Ritz,et al. Renal disease and hypertension in non-insulin-dependent diabetes mellitus. , 1999, Kidney international.
[25] R. Hutubessy,et al. Lifetime health effects and costs of diabetes treatment. , 2003, The Netherlands journal of medicine.
[26] F. Rutten,et al. The evidence-based approach in health policy and health care delivery. , 2000, Social science & medicine.
[27] Frode Gallefoss,et al. Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD--a 1-year follow-up randomized, controlled trial. , 2002, Respiratory medicine.
[28] R. Grol,et al. Empowering patients: how to implement a diabetes passport in hospital care. , 2002, Patient education and counseling.
[29] N Freemantle,et al. When is it cost-effective to change the behavior of health professionals? , 2001, JAMA.
[30] R. Grol,et al. Perceived barriers to the implementation of diabetes guidelines in hospitals in The Netherlands. , 2000, The Netherlands journal of medicine.
[31] L. Gaal,et al. Assessing the impact of complications on the costs of Type II diabetes , 2002, Diabetologia.
[32] R. Grol,et al. Introduction of diabetes passports involving both patients and professionals to improve hospital outpatient diabetes care. , 2005, Diabetes research and clinical practice.
[33] A. Zbrozek,et al. Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia , 1997, Diabetes Care.